Investigating the stability of malaria vaccines
Official title: Task V04: Malaria Vaccine Stability Study
Funded at Advanced Bioscience Laboratories, INC. · NIH-10137149 · Data updated 2026-11-12
This study is working on creating better and more reliable malaria vaccines to help protect people from this serious disease, so that in the future, we can have safer and more effective ways to prevent malaria.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2020 |
| Award (this year) | $167,151 |
| NIH project number | 272201800009I-P00001-759301900131-1 |
| Project ID | NIH-10137149 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of malaria infection, particularly in endemic regions.
✕Less likely to help
Patients who are not at risk of malaria or those who have already been vaccinated may not receive direct benefits from this research.
What this research studies
This research focuses on the development and stability of vaccines against malaria, a serious infectious disease. It involves the manufacture and characterization of vaccine components, ensuring they meet regulatory standards for safety and efficacy. Patients may benefit from improved malaria vaccines that are more effective and stable, potentially leading to better prevention strategies. The study includes various stages of product development, from planning to clinical trials, aimed at optimizing vaccine delivery and effectiveness.
Why it matters
Potential benefit: If successful, this research could lead to more effective and stable malaria vaccines, improving prevention and treatment options for patients.
How similar studies have gone: Previous research has shown success in developing vaccines for other infectious diseases, indicating potential for similar advancements in malaria vaccine development.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Fouts, Tmothy — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Tmothy
Related research
Other NIH-funded projects on the same topics.
-
Digital malaria surveillance in Ethiopia to improve outbreak detection
A collaboration to add a malaria-specific digital module to an existing surveillance system in Africa to help detect and respond to outbreaks faster.
-
Cross-sector partnership uses digital malaria surveillance in Ethiopia
A US-based team will adapt and test a digital malaria surveillance module in SORMAS to help detect and respond to malaria outbreaks in Ethiopia.
-
Malaria control project in Western Kenya to reduce illness and deaths
A large, multi-year effort in western Kenya will help track malaria spread and test ways to prevent transmission so fewer people get sick or die.
-
Optimizing tafenoquine dose to prevent relapse of vivax malaria in Asia
A study tests the best tafenoquine dose to prevent P. vivax malaria relapse in people in East Asia and Oceania.
-
Optimizing tafenoquine dose to prevent P. vivax malaria relapses in Asia
A study to find the best single-dose tafenoquine amount to prevent relapse of P. vivax malaria in people in East Asia and Oceania.
-
Severe malaria and brain risk in children
This grant studies how severe malaria in young children can affect brain development and long-term thinking and behavior, with a focus on kids in Uganda.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.